Please enable Javascript
fracture
Advertisement
Cohort Study Finds No Increased Fracture Risk with Canagliflozin
DocWire News Editors
Cardiology
|
September 14, 2023
Canagliflozin, recently approved for the reduction of heart attack and stroke risk in type 2 diabetics with known ...
Read More
Advertisement
Advertisement